G. Semensato et al., CD8(-LYMPHOCYTES IN THE LUNG OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENTS HARBOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1() T), Blood, 85(9), 1995, pp. 2308-2314
Human immunodeficiency virus-1 (HIV-1) infection of CD8(+) lymphocytes
has been described in several in vitro culture systems, but whether C
D8(+) cells are a target and also serve as a reservoir for infection i
n vivo as yet is unknown. We addressed this issue in patients with acq
uired immunodeficiency syndrome (AIDS)-related lower respiratory tract
chronic inflammation, which is characterized by a massive influx of C
D8(+) HIV-1-specific cytotoxic T lymphocytes (CTL). Proviral load in l
ung T lymphocytes and their subpopulations was evaluated by using the
DNA-polymerase chain reaction (PCR) technique on cells retrieved by br
onchoalveolar lavage. To avoid the possibility that the presence of HI
V-1 DNA could be caused by contaminating CD4(+) cells, serial dilution
s of highly purified CD8(+) cells were also analyzed by PCR. Our findi
ngs showed that lung CD8(+) cells harbor and express HIV-1. To explore
the possible mechanisms leading to pulmonary CD8(+) lymphocyte infect
ion, we evaluated CD4 gene expression on highly purified CD8(+) cells
by means of reverse transcriptase PCR, Despite the lack of membrane CD
4 reactivity, we could show that CD8(+) cells may express CD4 RNA, Coi
nfection of lung CD8(+) cells harboring proviral HIV-1 sequences by vi
ral agents capable of inducing CD4 expression (ie, HHV-6) was not dete
cted. Our data indicate that not only CD4(+) T lymphocytes and macroph
ages, but also CD8(+) cells, may represent a target and/or a reservoir
for HIV-1 in vivo, and suggest that lung CD8(+) lymphocytes could der
ive from precursors equipped with enough CD4 molecules to become HIV-1
permissive, Aside from the cell-to-cell contact between activated HIV
-1 specific CTL and relevant targets, the infection of precursors coul
d represent an additional mechanism accounting for the infection of pu
lmonary CD8(+) cells and their functional impairment. (C) 1995 by The
American Society of Hematology.